![CytoDyn Inc (QB)](/common/images/company/NO_CYDY.png)
CytoDyn is a clinical-stage biotechnology company focused on the development and commercialization of leronlimab, an investigational humanized IgG4 monoclonal antibody (mAb) that is designed to bind to C-C chemokine receptor type 5 (CCR5), a protein on the surface of certain immune system cells that... CytoDyn is a clinical-stage biotechnology company focused on the development and commercialization of leronlimab, an investigational humanized IgG4 monoclonal antibody (mAb) that is designed to bind to C-C chemokine receptor type 5 (CCR5), a protein on the surface of certain immune system cells that is believed to play a role in numerous disease processes. CytoDyn is studying leronlimab in multiple therapeutic areas, including infectious disease, cancer, and autoimmune conditions. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.006 | 4.4776119403 | 0.134 | 0.174 | 0.134 | 2639666 | 0.14293723 | CS |
4 | -0.002 | -1.40845070423 | 0.142 | 0.174 | 0.1275 | 2088939 | 0.13926432 | CS |
12 | -0.0105 | -6.97674418605 | 0.1505 | 0.315 | 0.1275 | 2597329 | 0.16960306 | CS |
26 | -0.0797 | -36.2767410105 | 0.2197 | 0.315 | 0.1275 | 2757417 | 0.17591534 | CS |
52 | -0.124 | -46.9696969697 | 0.264 | 0.418 | 0.1275 | 2327873 | 0.19047469 | CS |
156 | -1.44 | -91.1392405063 | 1.58 | 2.54 | 0.1275 | 2206150 | 0.53045395 | CS |
260 | -0.26055 | -65.048058919 | 0.40055 | 10.01 | 0.1275 | 2970347 | 2.10625574 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.